The results showed that diacerein, via modulation of proinflammatory cytokines (IL-1β and TNF-α), interferes with the onset of type 1 diabetes and may alter the incidence of autoimmune diabetes in treated animals. Here, IL1B is linked to type 1 diabetes mellitus.